Long-term results of thalidomide and dexamethasone (thal-dex) as therapy of first relapse in multiple myeloma
about
sameAs
Efficacy and toxicity of the combination chemotherapy of thalidomide, alkylating agent, and steroid for relapsed/refractory myeloma patients: a report from the Korean Multiple Myeloma Working Party (KMMWP) retrospective study.Enhanced immune-modulatory effects of thalidomide and dexamethasone co-treatment on T cell subsets.Novel agent-based salvage autologous stem cell transplantation for relapsed multiple myeloma.
P2860
Long-term results of thalidomide and dexamethasone (thal-dex) as therapy of first relapse in multiple myeloma
description
scientific article published on 08 September 2011
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в березні 2012
@uk
name
Long-term results of thalidomi ...... st relapse in multiple myeloma
@en
Long-term results of thalidomide and dexamethasone
@nl
type
label
Long-term results of thalidomi ...... st relapse in multiple myeloma
@en
Long-term results of thalidomide and dexamethasone
@nl
altLabel
Long-term results of thalidomi ...... st relapse in multiple myeloma
@en
prefLabel
Long-term results of thalidomi ...... st relapse in multiple myeloma
@en
Long-term results of thalidomide and dexamethasone
@nl
P2093
P2860
P50
P1433
P1476
Long-term results of thalidomi ...... st relapse in multiple myeloma
@en
P2093
Alessandro Petrucci
Beatrice Zannetti
Carolina Terragna
Elena Zamagni
Lucia Pantani
Michele Baccarani
Paola Tacchetti
Patrizia Tosi
P2860
P304
P356
10.1007/S00277-011-1320-2
P407
P577
2011-09-08T00:00:00Z